Streetbeat News

Products Services

AMZN

MSFT

Elon Musk made a surprise appearance at the 'Fallout' experience event at SXSW, supporting the Prime Video series adaptation of the game, owned by Amazon (AMZN) and Microsoft (MSFT) respectively. Musk's presence could hint at future support for the series, potentially boosting Amazon Prime Video subscribers and the video game franchise.

Portfolio Pulse from Chris Katje

March 08, 2024 | 9:08 pm

NTDOY

TM

Toyota Engineering Society has created a prototype motorcycle inspired by Miraidon, a Pokémon from Nintendo's game Pokémon Violet. This innovative project showcases Toyota's imaginative craftsmanship and pays homage to the game's versatile character. Although the motorcycle is not intended for commercial sale, it highlights Toyota's commitment to creative and technological advancements.

Portfolio Pulse from Franca Quarneti

March 08, 2024 | 9:02 pm

AAPL

Apple Inc (AAPL) has agreed to reinstate Epic Games' developer account, allowing 'Fortnite' to return to iOS in Europe. This decision comes after pressure from the European Union (EU) and is a significant test of the new Digital Markets Act (DMA), which mandates app stores to permit downloads from third-party sources. Epic Games had previously accused Apple of anticompetitive behavior, leading to their developer account being revoked. Apple's reversal follows the European Commission's investigation into these allegations.

Portfolio Pulse from Franca Quarneti

March 08, 2024 | 8:38 pm

DIS

Disney CEO Bob Iger announced that ESPN will continue to leverage its linear TV presence for revenue and profits while transitioning to streaming, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 8:35 pm

ETHUSD

MATICUSD

USDC

President Joe Biden's State of the Union speech and Super Tuesday results have positively impacted his odds for the 2024 presidential election, according to Polymarket. Former President Donald Trump also saw improved odds. Polymarket users bet on political outcomes using cryptocurrencies like Polygon (MATIC), USDC, and Ethereum (ETH). Current odds favor Trump at 54% and Biden at 33%. Betting trends indicate a slight shift in favor of the frontrunners, with Biden experiencing the largest increase in dollars wagered.

Portfolio Pulse from Chris Katje

March 08, 2024 | 8:35 pm

DIS

Disney CEO Bob Iger announced plans to make Hulu content available on Disney+ for bundle subscribers, aiming for positive business outcomes. Additionally, Disney is adopting a more aggressive cost management strategy at its film studios.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 8:33 pm

DIS

Disney CEO Bob Iger discussed the future of ESPN, highlighting its continued strength as a network. He mentioned that, eventually, ESPN will transition to being a fully digital platform.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 8:32 pm

DIS

Disney CEO Bob Iger announced that the company is on track to exceed its fiscal 2024 cash flow generation guidance. Additionally, he mentioned that Disney's streaming business is on a path to profitability, indicating positive future financial performance.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 8:32 pm

MRNA

Financial giants have shown a bullish stance on Moderna (NASDAQ:MRNA) through recent options trading, with a mix of bullish and bearish trades observed. The trading activity suggests a target price range of $40.0 to $115.0 for MRNA over the next three months. Moderna, a commercial-stage biotech company, has seen its mRNA technology gain rapid validation, especially with its COVID-19 vaccine. The current trading volume is 2,962,331 with the stock price at $99.48. Analysts have given mixed reviews, with an average target price of $100.67, ranging from $86 to $125.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 8:31 pm

IDYA

IDEAYA Biosciences (NASDAQ:IDYA) has received diverse analyst ratings over the past three months, with an upward trend in 12-month price targets, now averaging $52.33. This reflects a 29.53% increase from the previous average of $40.40. Analysts from firms including BTIG, JP Morgan, RBC Capital, and Goldman Sachs have adjusted their ratings and price targets, indicating a positive outlook on the company's performance. Despite facing revenue challenges and a net margin below industry averages, IDEAYA's strategic focus on oncology-focused precision medicine and its financial management are noteworthy.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 8:00 pm